A uniquely prevalent nonnucleoside reverse transcriptase inhibitor resistance mutation in Russian subtype A HIV-1 viruses

AN Kolomeets, V Varghese, P Lemey, MR Bobkova… - Aids, 2014 - journals.lww.com
Background: The subtype A variant in the Former Soviet Union (A FSU) causes most of
Russia's HIV-1 infections. However, the spectrum of drug-resistance mutations (DRMs) in …

[HTML][HTML] The emerging and re-emerging human immunodeficiency virus epidemics in Europe

I Bozicevic, S Handanagic, SZ Lepej… - Clinical microbiology and …, 2013 - Elsevier
We provide a summary of the current status of the human immunodeficiency virus (HIV)
epidemic, including data on the transmission of drug-resistant virus in the European Region …

HIV-1 sub-subtype A6: settings for normalised identification and molecular epidemiology in the Southern Federal District, Russia

M Schlösser, VV Kartashev, VH Mikkola, A Shemshura… - Viruses, 2020 - mdpi.com
Russia has one of the largest and fastest growing HIV epidemics. However, epidemiological
data are scarce. Sub-subtype A6 is most prevalent in Russia but its identification is …

Распространенность рекомбинантных форм ВИЧ-1 в регионах Российской Федерации и стран СНГ: систематический обзор и метаанализ

ОА Пасечник, АИ Блох - Инфекция и иммунитет, 2018 - cyberleninka.ru
Настоящий обзор посвящен оценке распространенности рекомбинантных форм ВИЧ в
России и странах СНГ, с которыми имеются тесные социально-экономические связи …

Identifying HIV-1 Transmission Clusters in Uzbekistan through Analysis of Molecular Surveillance Data

A Lebedev, A Kuznetsova, K Kim, E Ozhmegova… - Viruses, 2022 - mdpi.com
The CRF02_AG and sub-subtype A6 are currently the predominant HIV-1 variants in the
Republic of Uzbekistan, but little is known about their time-spatial clustering patterns in high …

Prevalence of pretreatment and acquired HIV-1 mutations associated with resistance to lamivudine or rilpivirine: a systematic review

V Vannappagari, L Ragone, C Henegar… - Antiviral …, 2019 - journals.sagepub.com
Background Pretreatment and acquired drug resistance mutations (DRMs) can limit
antiretroviral therapy effectiveness. Methods We review prevalence of DRMs with resistance …

Ten years survey of primary HIV-1 resistance in Serbia: the occurrence of multiclass resistance

M Stanojevic, M Siljic, D Salemovic… - AIDS research and …, 2014 - liebertpub.com
In Serbia, the first cases of HIV infection were reported in 1985, whereas antiretroviral (ARV)
therapy has been in use since 1987. With this study we aimed to assess the occurrence and …

Transmitted drug resistance is still low in newly diagnosed human immunodeficiency virus type 1 CRF06_cpx-infected patients in Estonia in 2010

R Avi, K Huik, M Pauskar, V Ustina, T Karki… - AIDS research and …, 2014 - liebertpub.com
The presence of transmitted drug resistance (TDR) in treatment-naive HIV-1-positive
subjects is of concern, especially in the countries of the former Soviet Union in which the …

The prevalence of HIV recombinant forms in Russia and countries of the CIS: systematic review and metaanalysis

OA Pasechnik, AI Blokh - Russian Journal of Infection and Immunity, 2018 - iimmun.ru
This review was to aimed to access the prevalence of HIV recombinant forms in Russia and
countries of the CIS, which have close social and economic ties. We conducted a search in …

[PDF][PDF] State of the Antiretroviral Therapy in Human Immunodeficiency Virus Drug Resistance: Surveillance and Regional Gaps.

CA Boucher, MR Bobkova, CC Hung, R Kaiser… - AIDS …, 2018 - researchgate.net
This article is the second of a two-part review aiming to identify gaps in the knowledge and
management of human immunodeficiency virus type 1 drug resistance (HIVDR) from global …